TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease.
Emily C Collins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.